| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0959-8049(01)00394-X |
| P698 | PubMed publication ID | 11872343 |
| P50 | author | Spyros Retsas | Q47364959 |
| P2093 | author name string | K Henry | |
| M Q Mohammed | |||
| K MacRae | |||
| P2860 | cites work | Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma | Q36292687 |
| Age as a prognostic factor in the malignant melanoma population | Q38572034 | ||
| Prognostic significance of the histological features of malignant melanoma | Q39979476 | ||
| Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients | Q40821958 | ||
| Individualized prognosis for melanoma patients | Q43430529 | ||
| Analysis of prognosis and disease progression after local recurrence of melanoma | Q43745393 | ||
| Cutaneous melanoma: prognosis and treatment results worldwide | Q44432993 | ||
| Experience with 998 cutaneous melanomas of the head and neck over 30 years | Q44773879 | ||
| A new American Joint Committee on Cancer staging system for cutaneous melanoma | Q44869575 | ||
| Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. | Q50857224 | ||
| Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. | Q51024425 | ||
| Thin malignant melanomas and recurrence potential | Q69416099 | ||
| Prognostic index for malignant melanoma | Q69745517 | ||
| Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis | Q69948186 | ||
| Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival | Q72359934 | ||
| Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? | Q77839287 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 511-516 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients | |
| P478 | volume | 38 |
| Q35687399 | A synopsis of serum biomarkers in cutaneous melanoma patients |
| Q35380959 | Angiogenesis and melanoma - from basic science to clinical trials. |
| Q81839067 | Cutaneous melanoma |
| Q30669529 | Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR). |
| Q36686387 | Evidence on prognosis |
| Q55167727 | Latest developments in the treatment of melanoma: 'a penicillin moment for cancer'? |
| Q34315676 | Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases |
| Q41144658 | Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma |
| Q35023404 | Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database |
| Q36381934 | Prognosticators of melanoma, the melanoma report, and the sentinel lymph node |
| Q37045206 | Sentinel lymph node evaluations |
| Q80755872 | Sentinel node biopsy confers no added protection to patients with melanoma |
| Q83204764 | The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma |
Search more.